期刊文献+

膀胱壁内注射A型肉毒毒素治疗脊髓损伤患者神经原性膀胱的初步临床观察 被引量:9

Treatment of neurogenic bladder associated with spinal cord injury with botulinum-A toxin injected into bladder wall
在线阅读 下载PDF
导出
摘要 目的:观察膀胱壁内注射A型肉毒毒素治疗脊髓损伤患者神经原性膀胱的临床效果。方法:78例脊髓损伤后神经原性膀胱患者,男59例,女19例,平均年龄38.9岁。将300单位A型肉毒毒素溶解于15ml生理盐水,使用膀胱镜注射针分30个点注射于膀胱壁,0.5ml/点。治疗前后均记录患者排尿日记,并观察药物毒副作用。结果:78例患者经第1次治疗后平均尿失禁次数由13.5次/d降至2.7次/d、平均导尿量由131ml/次增至389ml/次,平均尿失禁量由1690ml/d降至281ml/d,起效的平均时间为7.6d。10例患者在第1次注射8.9个月后接受第2次注射,平均尿失禁次数由9.7次/d降至3.7次/d,平均导尿量由108ml/次增至387ml/次。6例患者在第2次注射后5.8个月接受第3次注射,平均尿失禁次数由9.2次/d降至3.9次/d,平均导尿量由116ml/次增至364ml/次。随访期间未观察到任何毒副作用。结论:经尿道膀胱壁内A型肉毒毒素注射是治疗脊髓损伤患者神经原性膀胱的有效、安全、可多次重复应用的微创方法。 Objective:To evaluate the effects of botulinum-A toxin (BTX-A) injected into bladder wall to deal with neurogenic bladder associated with spinal cord injury(SCI).Method:Seventy-eight patients with SCI, male 59,female 19,with the mean age of 38.9 years,were included in the study.All patients wrote down the voiding diary,and underwent the urodynamic examination.300IU BTX-A was dissolved in 15ml normal saline, and the solution of BTX-A was injected into 30 different points (0.5ml/point) in detrusor using a flexible cystoscopic needle.The voiding diary and side effects were evaluated.Result:After the first injection of BTXA,the frequency of incontinence decreased from 13.5 to 2.7 times per day,the volume of incontinence reduced from 1690ml to 281ml,the volume for intermittent catheterization(IC) increased from mean 131ml to 389ml.10 cases received the second injection in 8.9 months after the first one;incontinence decreased from 9.7 to 3.7 times per day,the volume for IC increased from mean 108ml to 387ml.6 cases received the third injection in 5.8 months after the second one;incontinence decreased from 9.2 to 3.9 times per day,the volume for IC increased from mean 116 ml to 364 ml.No side effects were observed.Conclusion:It suggests that Botulinum-A toxin injected into bladder wall to treat neurogenic bladder in the patients with SCI is an effective,safe,repeatable solution.
出处 《中国脊柱脊髓杂志》 CAS CSCD 2005年第12期719-721,共3页 Chinese Journal of Spine and Spinal Cord
关键词 A型肉毒毒素 膀胱壁 神经原性膀胱 脊髓损伤 Botulinum-A toxin Bladder wall: Neurogenic bladder Spinal cord injury
  • 相关文献

参考文献10

  • 1Schurch B,Stoehrer M,Kramer G,et al. Chyperreflexia in spinal cord injured patients:a new alternative to anticholinergic drugs?Preliminary results[J].J Urol, 2000,164 ( 3 ): 692-697.
  • 2廖利民,李东,熊宗胜,韩春生,黄悦,史文博.经尿道膀胱壁A型肉毒毒素注射治疗脊髓损伤患者逼尿肌反射亢进及神经原性尿失禁[J].中华泌尿外科杂志,2004,25(9):596-598. 被引量:39
  • 3Abrams P,Cardozo L,Khoury S,et al. Incontinence[M].Pairs:Health Publication Ltd ,.2002.1115-1116.
  • 4Abrams P,LarssonG,Chapple C,et al.Factors involved in the success of antimuscarintc treatment[J].BJU Int,1999,83 (Suppl) :42-47.
  • 5De Seze M ,Wiart L, Joseph PA, et al. Capsaicin and neurogenic detrusor hyperreflexia:a double-blind placebo-controlled study in 20 patients with spinal cord lesions [J].Neurourol Urodyn, 1998,17 (5): 513-523.
  • 6Chancellor MB,De Groat WC.Intravesical capsaicin and resiniferatoxin therapy:spicing up the ways to treat the overactive bladder[J].J Urol, 1999,162 ( 1 ): 3 - 11.
  • 7Brindley GS. The first 500 patients with sacral anterior root stimulator implants :general description [J].Paraplegia, 1994,32(12) :795-805.
  • 8Madersbacher H,Wyndaele JJ,Igawa Y,et al.Conservative Management in the Neuropathic Patient. In:Abrams P,Khoury S,Wein A,eds. Incontinence[M].Plymouth:Health Publication Ltd,1999.777-812.
  • 9Karsenty G,Boy S,Reitz A,et al. Botulinum toxin-A(BTA) in the treatment of neurogenic detrusor overactivity incontinence (NDOI) :a prospective randomized study to compare 30 vs 10injection sites [R].In:2005 Annual Meeting of International Continence Society. Montreal, Canada: 2005.93.
  • 10Brading A. Physiology of Bladder Smooth Muscle. In:Torrens M,Morrison JFB,eds.The Physiology of the Lower Urinary Tract[M].New York: Springer-Verlag, 1987.161-192.

二级参考文献9

  • 1Schurch B, Stoehrer M, Kramer G, et al. Botulinum -A toxin for treating detrusor hyperreflexia in spinal cord injured patients:a new alternative to anticholinergic drugs? Preliminary results. J Urol, 2000,164:692-697.
  • 2Abrams P,Larsson G, Chapple C, et al. Factors involved in the success of antimuscarintc treatment. BJU Int, 1999,83 (suppl) :42-47.
  • 3Brindley GS. The first 500 patients with sacral anterior root stimulator implants: general description. Paraplegia, 1994,32: 795-805.
  • 4de Seze M, Wiart L, Joseph PA, et al. Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn, 1998,17: 513-523.
  • 5Chancellor MB ,de Groat WC. Intravesical capsaicin and resiniferatoxin therapy:spicing up the ways to treat the overactive bladder. J Urol,1999,162:3-11.
  • 6Madersbacher H, Wyndaele JJ, Igawa Y, et al. Conservative management in the neuropathic patient. In:Abrams P, Khoury S and Wein A,eds. Incontinence. Plymouth: Plymbridge Distributors, 1999. 777-812.
  • 7Brading A. Physiology of bladder smooth muscle. In:Torrens M, Morrison JFB, eds. The physiology of the lower urinary tract. New York:Springer-Verlag, 1987. 161-192.
  • 8Schurch B,Hauri D,Rodic B,et al. Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol, 1996,155:1023-1027.
  • 9Molgo J, Comella JX, Angaut-Petit D, et al. Presynaptic action of botulinal neurotoxins at vertebrate neuromuscular junctions. J Physiol,1990,84:152-157.

共引文献38

同被引文献174

引证文献9

二级引证文献239

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部